FOXO1 and preeclampsia: As mentioned, HDAC9 alters the acetylation status of FOXO1, promoting its activation [51]; therefore, some deleterious cellular complications in preeclampsia may be a consequence of FOXO1 dysregulation secondary to the loss of HDAC9.